On the Pulse of


Mirai Medical logo white
Scan of Gastrointestinal Therapy

Gastrointestinal Therapy

ePORE® therapy is a precision cancer treatment addressing critical unmet challenges and symptom relief for gastrointestinal cancers.
Medical professional examining a patients back and neck area

Skin Therapy

Delivered under local anaesthesia as a day case procedure, ePORE® therapy can be used in combination with chemotherapy for the local control of a wide range of skin cancers.
Scan of Gastrointestinal Therapy

Gastrointestinal Therapy

ePORE® therapy enables every endoscopist to treat at diagnosis

Value Award Winners

Play Video

How It Works

Please accept marketing cookies to view this video.
Dr Declan Soden's mission speech in graphic

Addressing critical unmet challenges in gastrointestinal disease

In Europe an estimated 15% of new cases and 13.7% of deaths will be due to Colorectal Cancer by 2040
European Cancer Information System. (2021). Colorectal Cancer Burden in EU-27. Brussels: European Commisson.
Early-onset Colorectal Cancer, affecting individuals less than 50 years old is on the rise, particularly in high-income countries
Akimoto, N. (2020). Rising incidence of early- onset colorectal cancer — a call to action. Nature Reviews Clinical Oncology, https://doi.org/10.1038/s41571-020-00445-1
In the USA, Colorectal Cancer had the greatest increases in the number of incident cases of young onset GI cancer in 2019.
Reference: https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2808381

Targeted Therapy
Big Results.

Icon depicting improved patient experience

Precision Based Treatment

Icon of a hand holding cash

Cost Effective Treatment

Icon of a hand holding a lightbulb

An Alternative Treatment

Years of Experience

We bring together some of the best minds in electroporation and therapeutic development expertise.

DR Declan Soden Founder & CEO of Mirai Medical
Dr. Declan Soden
Founder & Chief Executive Officer
Colin Forde
Chief Operating Officer
Simon Ombler, sales and marketing director at Mirai Medical
Simon Ombler
Sales & Marketing Director
Seán Kinsella
Chief Technical Officer

Patient Experience

Hear about the positive experience of a skin cancer patient who underwent ePORE® therapy treatment.

Please accept marketing cookies to view this video.

Follow Our Progress

By clicking submit, you agree to receive communications and updates from Mirai Medical, and acknowledge Mirai Medical's Privacy Policy.
This field is for validation purposes and should be left unchanged.